Condition: Osteoarthritis · Knee Pain Arthritis · Cartilage Defects of the Knee · Sponsor: DALIM TISSEN Co., Ltd.
This clinical trial aims to evaluate and compare the efficacy and safety of CartiPRO, an approved intra-articular atelocollagen injection, versus Synovian injection for the relief of knee pain in patients with knee osteoarthritis. The investigational device is administered intra-articularly, with a second injection given 24 weeks after the first dose. Primary and secondary endpoints include changes in pain scores (VAS), functional assessments (WOMAC, SF-36), and safety evaluations over a 36-week period.
This description comes directly from the study's public registry record.
Hyunjin Bae Dream CIS · +82 2 2010 450 · su-bin.lee@tigermedgrp.com
Always discuss trial participation with your own doctor first.
| Seoul National University Bundang Hospital | Seongnam-si, Bundang-gu, South Korea | Recruiting |
| CHA Bundang Medical Center | Seoul, Bundang-gu, South Korea | Recruiting |
| The Catholic University of Korea Eunpyeong St. Mary's Hospital | Seoul, Eunpyeong-gu, South Korea | Recruiting |
| Gachon University Gil Hospital | Seoul, Namdong-gu, South Korea | Recruiting |
| The Catholic University of Korea Seoul St. Mary's Hospital | Seoul, Seochogu, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07267793